semaglutide weight loss newport beach Supplements Coast | Medical Weight Loss 2026 semaglutide weight loss program orange

Ozempic is a GLP-1 receptor agonist licensed for managing type 2 diabetes mellitus

Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) activates two receptors GLP-1 and GIP which is why it tends to produce somewhat stronger weight-loss results on average

Whilst our Wegovy and Mounjaro weight-loss programmes are private and not currently used by the NHS, weve built the programmes focusing on scientific evidence, patient safety, and data security

Strategy 3: Structured drug holiday with behavioral bridging

He has received grant support from AstraZeneca, Eli Lilly & Co., Menarini/Berlin-Chemie, Merck, Sharp & Dohme, Novartis Pharma, and Novo Nordisk